Acidic microenvironment, particularly acid-sensing ion channel 1a (ASIC1a), has been reported to promote carcinoma cell proliferation as well as migration. In this study, we explored the effect of ASIC1a on migration and invasion of gastric carcinoma (GC). ASIC1a expression levels were examined in paired GC and adjacent normal tissues from 16 patients by immunohistochemistry. Reverse transcription real-time PCR and immunoblotting were conducted to assess the ASIC1a expression levels in the GC cell line AGS after transfection with ASIC1a small hairpin RNA (shRNA). Wound healing and transwell invasion assays were utilized to detect metastasis and invasion following ASIC1a silencing. Tumor formation was used to detect the role of ASIC1a in tumorigenicity in vivo. It was found that ASIC1a expression level was significantly higher in GC tissues showing postoperative metastasis compared with non-metastasis and non-tumor tissues. Moreover, silencing of ASIC1a with shRNA significantly down-regulated ASIC1a expression and reduced GC cell migration and invasion. A moderately acidic extracellular environment inhibited GC cell viability. Furthermore, ASIC1a shRNA caused inhibition of tumorigenicity in vivo. Our study is the first report of attenuating the malignant phenotype of GC in vitro and in vivo by suppressing ASIC1a, and suggests a novel approach to study the relationship between ASICs and GC cell migration and invasion.
Introduction
Gastric acid is dominantly important for digesting food and protecting from pathogens, while it is also a threat for the mucosa integrity in upper gastrointestinal tract, which may cause pain in case of inflammation and ulceration [1] . The malignant tumors have the major feature of acidic extracellular pH, which is also the characteristic of injured tissue [2] . Acid-sensing ion channels (ASICs), as H + -gated cation channels, are broadly expressed in the mammalian central and peripheral nervous systems, and function in pain perception, learning, memory, and fear conditioning [3] . ASIC overactivation is related to neurodegenerative diseases, such as ischemic brain/spinal cord injury [4] , multiple sclerosis [5] , Parkinson's disease [6] , and Huntington's disease [7] . To date, at least six subunits of ASICs, namely 1a, 1b, 2a, 2b, 3, and 4, have been identified. ASIC1a is of top interest for research due to its critical biological functions and significant pathological importance.
Under most pathological circumstances, such as in injured tissues, extracellular pH value is around 6.5. The function of acidosis is critical in cell injury including tumor and tissues exposed to inflammation and ischemic injury. Evidence from clinical pathology demonstrates that pumps and transporters contribute to the secretion of H + , and ASICs are believed to participate in the process [8] [9] [10] . Studies suggested that ASIC1a might be related to proliferation and migration of tumors, and ASIC1a expression as well as its role was recently reported in malignant gliomas [11] . Yet, ASIC1a function in solid tumors, especially in gastric carcinoma (GC), remains unclear.
It would allow early detection of patients with gastric acid and ASICs levels at increased risk of developing GC. We therefore hypothesized that ASIC1a may regulate GC migration and invasion. To test this hypothesis, we examined ASIC1a expression in human GC tissues as well as in cancer cells, and investigated whether ASIC1a regulates the migration and invasion of the GC cell line AGS.
Materials and Methods

Patient enrollment and tissue collection
The experiments in this study were performed according to the protocols permitted by the Human Research Ethics Committee of Soochow University and the First Hospital Affiliated to Soochow University (Suzhou, China). From 2013 to 2015, 16 GC tissues were attained from patients undergoing surgical resection with paired adjacent non-tumor tissues as the control. Informed consent was obtained from each patient. After resection, tissue samples were put into liquid nitrogen immediately for frozen and then stored at −80°C. Tumor tissues and adjacent non-tumor tissues were examined for pathology. The characteristics of patients, including gender, age, pathology, and the stage of tumor metastasis, were collected and recorded (Supplementary Table S1 ).
Cell culture
The GC cell line AGS was attained from Shanghai Institutes for Biological Sciences of the Chinese Academy of Sciences (Shanghai, China) and cultured in DMEM (Invitrogen, Carlsbad, USA) with 10% fetal bovine serum (Sijiqing Biological Engineering Materials Co., Hangzhou, China), 100 μg/ml streptomycin and 100 U/ml penicillin at 37°C with 5% CO 2 in a humidified incubator. The medium was refreshed every 48 h, and three media with different pH, i.e. pH 6.5 and pH 7.4, were used. Trypsin (0.25%) was used to digest and passage cells. Wound healing and invasive behavior of AGS cells were assessed in acidic (pH 6.5) as well as in normal microenvironment (pH 7.4). PcTx1 (100 nM, ab120483; Abcam, Cambridge, USA), an ASIC1a-specific inhibitor, was used to treat AGS cells to investigate the effect of the ASIC1a.
Western blot analysis
Western blot analysis was performed as described previously [12] . Cells after treatment were harvested, washed three times with ice-cold PBS. Then, 50 μl lysis buffer (Beyotime Institute of Biotechnology, Shanghai, China) was added and incubated 10 min on ice. After 16-s sonication and 15-min centrifugation at 13,400 g at 4°C, bicinchoninic acid Protein Assay Kit (Beyotime) was utilized to determine the protein concentration of the supernatants. SDS-PAGE loading buffer (Beyotime) was added to 30 μg protein samples and boiled at 100°C for 5 min. Samples were subject to 10% SDS-PAGE and then transferred to polyvinylidene difluorid (PVDF) membrane (Millipore, Burlington, USA). The membrane was then blocked with 5% non-fat milk for 1 h in Tris buffered saline with Tween 20 (TBST) buffer containing 150 mM NaCl, 50 mM Tris, pH 7.6, and 0.1% Tween 20. Then the membrane was incubated with anti-ASIC1 antibody (sc-13903; Santa Cruz Biotechnology, Dallas, USA) at 4°C overnight, or with mouse monoclonal anti-β-actin antibody (1:1000; Beyotime) as the loading control. After three times of wash with TBST buffer, the membranes were incubated with HRP-conjugated secondary antibody and finally visualized using TMB-stabilized substrate (Promega, Madison, USA). ImageJ software (NIH, Bethesda, USA) was utilized to perform densitometric analysis for the target protein bands.
Immunohistochemistry
Immunohistochemistry (IHC) analysis was performed as described previously [13] . Dako EnVision Detection Kit (Agilent, Santa Clara, USA) was used in immunohistochemical staining following the manufacturer's protocol. Briefly, paraffin-embedded tissue sections at 4 μm thick were cut and mounted onto gelatin or poly-L-lysine coated slides and dried by air, deparaffinized by xylene, and rehydrated. A microwave oven was used for antigen retrieval for 15 min using citrate buffer with a concentration of 10 mM and pH 6.0. After being blocked with 3% H 2 O 2 solution to quench endogenous peroxidase activity, slides were blocked with 10% goat serum for 10 min and then incubated with primary anti-ASIC1 antibody overnight at 4°C. Then slides were incubated with a diluted appropriate secondary antibody conjugated with HRP for 30 min. Three times of wash with PBS were performed among steps, and negative controls (non-tumor tissues) were included during the process. IPP 6.0 software (Media Cybernetics, Rockville, USA) was utilized for the semi-quantitative analysis of ASIC1a protein level.
Reverse transcription PCR
Quantitative real-time PCR was performed as described previously [14] . After AGS cells were collected by centrifugation and washed two times with PBS, 100 μl PBS was used to resuspend cells. RNA Safe Kit (Bio 101, Vista, USA) was utilized to isolate total RNA and then Poly(A+) mRNA was extracted by mRNA Kit Oligo [dT]30 (Bio 101). The mRNA concentrations were measured by spectrophotometry (GENSYS 10S; Thermo Fisher Scientific, Waltham, USA). Then 0.2 μg AGS mRNA was used to synthesize cDNA with oligo dT primers by Thermoscript RT-PCR Kit (Bio 101). Reactions were conducted in the volume of 50 μl containing 2 μl cDNA, 1.5 mM MgCl 2 , 1 × buffer, 4 μM sense and antisense primers, 0.2 mM dNTP, and 2 U Platinum Taq DNA polymerase (Life Technologies, Carlsbad, USA). PCR was conducted for 35 cycles with the program of 30 s at 94°C and 2 min at 70°C. Rat brain cDNA was used for ASIC1a amplification as the positive control. Amplification products were examined on a 2% agarose gel. The following primers were used: ASIC1a forward, 5′-GGGCCCTTGGGAGATATTTGG-3′ and reverse, 5′-GTCACGTGTGGGTAGCTGAG-3′ (308 bp); β-actin forward, 5′-CTGGGACGACATGGAGAAAA-3′ and reverse, 5′-AAGGAAGGCTGGAAGAGTGC-3′ (534 bp).
shRNA construction and establishment of stable cell lines
The sequence of ASIC1a small hairpin RNA (shRNA) (NM_020039) was as follows: 5′-GATCCCCTATGGAAAGTGCTACACGTTCT CGAGAACGTGTAGCACTTTCCATAGTTTTTGGAT-3′ (1) and 5′-AGCTATCCAAAAACTATGGAAAGTGCTACACGTTCTCGA GAACGTGTAGCACTTTCCATAGGG-3′ (2) [15] . The negative control sequence was 5′-TTCTCCGAACGTGTCACGTT-3′ and was introduced into GV102 plasmid. The plasmids were synthesized by Shanghai GeneChem Inc. (Shanghai, China) and transfected to AGC cells using the Lipofectamine 2000 reagent (Invitrogen) following manufacturer's protocol. The transfected cells were cultured in a 6-well plate where stably transfected AGC cells were selected after being cultured in the presence of G418. Following selection, stable cell populations were identified and designated as negative control and ASIC1a shRNA cells. The interference efficiency of shRNAs was determined by western blot analysis and RT-PCR, then two ASIC1a clones (shRNA) were chosen to do the further detection from different sequences that showed better silencing effect.
Cell proliferation assay
Cell proliferation assay was performed as described previously [14] . Colorimetric Cell Viability Kit cell proliferation assay reagent (Roche Diagnostics, Indianapolis, USA) was used to determine the cell proliferation according to the manufacturer's protocol. Proliferation was calculated with respect to control cells and was plotted using KaleidaGraph 3.0.1 (Synergy Software, Reading, USA) or Excel (Microsoft, Redmond, USA).
Wound healing assay
Wound healing assay was performed as described previously [16] . AGS cells were seeded at a density of 1.0 × 10 5 cells/well in 6-well plates. When cells reached 90% confluence, shRNA transient transfection was performed. After 24 h, AGS monolayer cells were cultured in serum-free medium for 12 h to minimize the proliferation as well as to enhance the influence of migration on wound healing. In wounding healing assay, cell monolayer was scraped with a 200-μl pipette tip followed by two times of gentle wash with PBS. Images of cell layer in the wounded area were taken between 0 h and 24 h after injury using a microscope (Canon, Tokyo, Japan) equipped with a digital camera. A grid was attached to bottom of cell culture plates and was utilized as the reference point for the same location in the images. ImageJ software was used to determine the wound healing of the scraped areas.
Invasion assay
Transwell assay was used to measure the cell invasion activity. A total of 1 × 10 4 cells in 200 μl serum-free medium were seeded in upper chambers of transwells (24-well inset, 8-μm pore size; Corning Co., Corning, USA) coated with Matrigel. Then, 600 μl medium with serum was aliquoted into the lower chambers. After 24 h, cells not migrating or invading through the pores were detached by cotton swabs. Invaded cells on the filters were fixed with 90% ethanol, then stained with 0.1% crystal violet, and images were taken. Cells were counted with three repeats.
Animal model
Immunodeficiency Balb/c nude mice were obtained from the Center for Experimental Animal, Soochow University (Certificate No.
20020008, Grade II). NIH Guidelines for the Care and Use of Laboratory Animals were followed in all animal procedures. Mice were randomly assigned into four independent groups (10 mice in each group), i.e. medium control group, control shRNA group, ASIC1a shRNA1 group, and ASIC1a shRNA2 group. Mice were subcutaneously injected with 5 × 10 6 cells or medium only into the left hind leg. Animals were examined daily for signs of distress or development of jaundice. Then, five mice in each group were sacrificed after 5 weeks of cell injection, and tumor weight was measured. Animal survival of the other five mice in each group was evaluated from the first day of treatment to the death of the mouse. To minimize animal sufferings, mice were euthanized when they became moribund according to predefined criteria like rapid weight loss (>20%) or weight gain (>20% due to ascites), loss of ability to ambulate, labored respiration, or inability to drink or feed.
Statistical analysis
Student's t-test was used for two-group comparisons. For multiplegroup comparisons, one-way analysis of variance followed by Fisher's least significant difference (assuming equal variances) or Dunnett's T3-test (assuming unequal variances) was performed. P < 0.05 was considered statistically significant.
Results
ASIC1a overexpression contributes to the metastasis stage of advanced tumors
To investigate if acidic microenvironment promoted proliferation and migration of carcinoma cells, we analyzed the microarray data between nine gastric cancer samples and nine non-cancer tissues (Query DataSets for GSE19826). Expression of ASIC1a was detected above background levels, and ASIC1a was upregulated in gastric cancer samples compared with non-cancer tissues from the same patients (Fig. 1A) . Furthermore, 16 GC tissues were collected with the paired adjacent non-tumors as the controls, and expression of ASIC1a was detected by immunohistochemistry, western blot analysis, and RT-PCR. GC tissues showing postoperative metastasis displayed significantly higher ASIC1a expression compared to those of non-postoperative metastasis as well as non-tumor tissues by immunohistochemistry analysis (Fig. 1B) . Furthermore, western blot analysis and RT-PCR results showed that protein and mRNA levels of ASIC1a in postoperative metastasis were higher than those in non-postoperative metastasis or non-tumor tissues (Fig. 1C,D) . These results indicated that upregulation of ASIC1a was positively correlated with advanced stage of tumor metastasis in GC.
Silencing of ASIC1a expression by shRNA in AGS cells
To study the role of ASIC1a in the cell migration and invasion of the AGS cells, we constructed a shRNA plasmid specifically targeting ASIC1a in acidic medium with pH 6.5. Two ASIC1a-silencing clones (shRNA) were selected based on the results of western blot analysis ( Fig. 2A,B) and RT-PCR assay (Fig. 2C) , which showed better silencing effect. It was shown that expression of ASIC1a was significantly down-regulated compared to the plasmid-expressing control and untransfected cells at both mRNA and protein levels (P < 0.05). These data indicated that the silencing of ASIC1a was effective by shRNA transfection.
Cell proliferation was not significant inhibited by a microenvironment of pH 6.5 to pH 7.4 by ASIC1a silencing
Cell proliferation assay was performed to detect the proliferation of AGS cells at pH 7.4 and 6.5, respectively, 48 h after transfection. The results showed that the proliferation of AGS cells was greatly inhibited in a microenvironment of pH 6.5 compared with that in a microenvironment of pH 7.4 (P < 0.01). However, the proliferation of ASIC1a shRNA cells was not significantly inhibited in the microenvironment of pH 6.5 compared with that in the microenvironment of pH 7.4 ( Fig. 2D , P > 0.05). These data indicated that the proliferation of AGS cells was inhibited under acidic pH condition, however no significant inhibition was found after ASIC1a silencing.
ASIC1a silencing inhibits the migration and invasion of AGS cells in vitro
Migration and invasion of cancer cells play a very important role for clinical pathology and malignancy. To study the function of ASIC1a in this process, ASIC1a silencing was performed by shRNA in AGS cells, and then the migration ability was assessed. The scratch wound healing assay was performed by creating a 1-mm wide wound in a monolayer of AGS cells transfected with either ASIC1a shRNAs or control shRNA. After 24 h, migration of AGS cells to the wound area was reduced significantly after ASIC1a silencing (Fig. 3A,B) . Because ASIC1a shRNA inhibited cell migration, we next investigated whether ASIC1a can regulate cell motility using the transwell invasion assay. As shown in Fig. 3C , the number of invaded cells through Matrigel-coated membrane was decreased after ASIC1a-silencing, and it demonstrated that ASIC1a downregulation greatly inhibited the invasion of cells compared with the control shRNA. These data indicated that silencing of ASIC1a inhibited AGS cell migration and invasion in vitro.
Effect of ASIC1a silencing on AGS cell tumor formation in vivo
As migration and motility of tumor cells are prerequisites for the development of AGS cell metastasis, and the tumor microenvironment plays an important role in tumorigenesis, it is essential to evaluate the role of ASIC1a in vivo. Here, nude mice were injected with AGS cells transfected with control shRNA, ASIC1a shRNA1, or shRNA2; and nude mice injected with medium only were used as a control. The results showed that ASIC1a shRNA caused robust suppression in tumorigenicity in terms of tumor weight 5 weeks after injection (Fig. 4A,B , P < 0.05). Survival time was significantly increased in either ASIC1a shRNA1 or ASIC1a shRNA2 group when compared with control shRNA group in inflammation mouse model, consistent with results obtained from the pH 6.5 in vitro cell models (Fig. 4C) . Five animals died between Days 15 and 20 in the control shRNA group, and all mice in ASIC1a shRNA groups died between Days 20 and 31 after injection (Fig. 4C ).
Discussion
In this study, we found that ASIC1a silencing inhibited GC cell migration and invasion in vitro, and ASIC1a silencing caused inhibition of tumorigenicity in vivo. These results suggest that the ASICs are likely related to GC cell migration and invasion. ASIC1a, a proton-gated ion channel functioning for the transport of Ca 2+ , is expressed in the mammalian nervous system and cells of other tissues such as bone, taste cells, disc cells, and lung epithelial cells [17, 18] . It was shown in our previous study that ASIC1a mediated the regulatory effect of paeoniflorin on the autophagy of alpha-synuclein involved in the development of Parkinson's disease [6] . Moreover, ion channels function importantly in the proliferation, growth, migration, and/or invasion of cancer cells, as well as in tumor therapy resistance [19, 20] . Recently, researchers have reported that deficiency of acidification and oxygen, which resulted in similar pathologies, is among the main characteristics of the microenvironment of liver cancer [21, 22] . However, there is no evidence suggesting any relationship between ASIC1a and GC. Gastric acid is a risk to mucosa integrity of upper gastrointestinal tract, and cause pain during inflammation or ulceration [23] . Importantly, researches have provided much evidence that ASICs not only participate in the hypersensitivity and pain of gastric acid during peptic ulceration and gastritis but also contribute to the hypersensitivity of colons to the mechanical stimuli, such as distension, during the process of irritation that is not necessarily related to overt inflammation [24, 25] . It has been reported that the secretion of gastric acid is tightly controlled by inhibitory feedback machineries, and acid-induced mucosa injury induces systemic warning signals by causing gastric mucosa injury. Our study also showed that proliferation of AGS cells was inhibited by ASIC1a activation induced by acidic pH. The pH level in esophagus, stomach, and intestine is checked by a network of acid sensors, among which ASICs and acid-sensitive members of potential ion channels of transient receptors are closely implicated [26] . These important functional implications and their induction by inflammatory or non-inflammatory pathologies make ASICs as potential targets for functional management of gastrointestinal disorders and GC. We therefore hypothesize that ASIC1a may be involved in GC by increasing gastric acid.
In conclusion, we hereby report that the upregulation of the mRNA and protein level of ASIC1a in GC tissues, and the expression of ASIC1a was significantly higher in GC tissues with postoperative metastasis in comparison with those without postoperative metastasis and non-tumor tissues. These results suggest that the upregulation of ASIC1a has a positive correlation with advanced metastasis stage of GC tumors. Moreover, inhibition of ASIC1a attenuates acid-induced AGS cell migration and invasion, thus providing strong evidence implicating ASIC1a in GC progression. These findings provide the basis for further exploration of the potential regulator for the development of GC. 
